Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)
Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)
Prospective observational study of Parkinson's disease with repeat clinical assessment and
 biobanking of blood samples.
To identify genetic and biomarker factors which affect the expression of Parkinson's Disease.

 Primary objective: To define the severity and rates of progression of clinical features of
 Parkinson's Disease.

 Secondary objective: To relate clinical phenomenology of Parkinson's disease to genetic and
 biomarker changes.
A. Parkinson's Disease patients

 Inclusion criteria

 1. Diagnosis of Parkinson's disease, based on UK Brain Bank criteria and made within the
 preceding 3 years ('recent onset cases') or diagnosed at under 50 years ('under 50
 years cases')

 2. Age ≥18 to <90years

 3. Subject is able and willing to provided informed consent.

 Exclusion criteria

 1. Patient has severe comorbid illness that would prevent full study participation

 2. Patient has features indicating another type of degenerative parkinsonism, e.g.
 progressive supranuclear palsy

 3. Drug-induced parkinsonism (Drug-unmasked PD is allowed)

 4. Symmetrical lower body parkinsonism attributable to significant cortical and/or
 subcortical cerebrovascular disease (patients with 'incidental' small vessel disease
 on brain imaging are allowed).

 5. Negative or normal functional imaging of the presynaptic dopamine system

 6. The presence of UK Brain Bank exclusion criteria will be recorded at baseline,
 allowing for the presence of 1 or 2 exclusion criteria (e.g. dopamine antagonist Drug
 used; more than one affected relative) (if justified e.g. by abnormal SPECT).

 B. First degree relatives Inclusion criteria

 1. Age ≥18 to < 90years

 2. Resident in the United Kingdom and able to access one of the PRoBaND study centres.

 3. Subject is able and willing to provided informed consent.

 Exclusion criteria

 1. Subject has severe comorbid illness that would prevent study participation

 2. Subject already has a diagnosis of Parkinson's disease